Gene Therapy Tools
- Ref-No. Technology
-
01-00986
Non-invasive and high-throughput monitoring of exon-specific isoform expression
-
01-01085
Expansion of pancreatic progenitors derived from human pluripotent stem cells und GMP-compliant conditions
-
02-00369
Biodynamers enhance drug delivery
-
03-00251
Stable Gene Transfer with Hyperactive Sleeping Beauty Transposase SB100X
-
03-00413
Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
-
03-00431
CrispRGold - Design of efficient CrispR/Cas sgRNA sequences and off-target prediction
-
03-00453
Homology Independent Genomic Sequence Replacement
-
03-00481
Spacer-nick genome editing of hematopoietic stem and progenitor cells and T cells
-
03-00539
Sleeping Beauty transposase variants with increased safety due to reduced half-life
-
03-00541
Safer Sleeping Beauty transposase variants with improved integration profiles
-
03-00542
Activity-enhanced variant of hyperactive Sleeping Beauty transposase SB100X
-
15-00648
AAV Vector Variants for Ocular Gene Delivery
-
15-00728
Non-integrating alpharetrovirus-based vector particles for efficient RNA delivery and targeted gene modification
-
15-00740
Maintenance of regulatory T cell phenotype by expression of IL-2 fusion protein
-
32-00082
Reprogramming immune cells for CAR cell-based therapies
-
32-00083
Immunosuppressant resistance in anti-viral T cell products
-
32-00101
High-level recombinant adeno-associated virus production
-
32-00124
CD3-CAR NK-92 cell-mediated TCR+ depletion
-
32-00128
Method for Assessing Out-of-Specification (OOS) CAR T-Cell Products and Predicting Patient Response
-
32-00164
The CXCR3alt-CXCL11 chemokine system for therapeutic use in solid cancer
-
32-00192
Base editing enzymes for multiplex editing with simultaneous gene knock-in and knock-out
-
32-00202
An engineered serine integrase for targeted gene transfer in human cells
-
40-00003
BreakTag - Novel method for detection of ds-breaks and analysis of CRISPR-induced on- and off-target effects
-
43-00004
CRISPR Switch: Inducible sgRNA expression for tightly regulated, efficient and safer CRISPR/Cas9 genome editing
-
43-00013
CRISPR StAR: facilitating high resolution genetic screening in complex in vivo models
